Search Within

Shyamprasad Deraje Vasudeva

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Department of Medicine (5)
  2. Sarcoma Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Pediatrics, Department of (2)
  5. Sarcoma Service (Pediatrics) (2)
  6. Biostatistics Service (1)

More Groups

People
  1. William Tap (5)
  2. Gary Schwartz (3)
  3. Elisa De Stanchina (2)
  4. Emily Slotkin (2)
  5. Parag Patwardhan (2)
  6. Abdul Abdullah (1)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2013 (3)
Publications
  1. Cancer Research (3)
  2. Lancet Oncology (1)
  3. Molecular Cancer Therapeutics (1)
Publishers
  1. American Association for Cancer Research (4)
  2. Elsevier Science, Inc. (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma
    Journal Article

    Slotkin, E. K.; Patwardhan, P. P.; Vasudeva, S. D.; de Stanchina, E.; Tap, W. D.; Schwartz, G. K.
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • Potent antitumor activity of MLN0128, an investigational selective mTORC1/2 kinase inhibitor, in preclinical models of rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E.; Patwardhan, P.; Deraje, S. V. ; Schwartz, G.; Tap, W.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • MLN0128, an investigational selective TORC1/2 kinase inhibitor, demonstrates potent antitumor activity in preclinical models of soft tissue sarcoma
    Meeting Abstract

    Patwardhan, P.; Deraje Vasudeva, S.; Tap, W. D.; de Stanchina, E.; Schwartz, G. K.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • KPT-330, a selective small molecule inhibitor of nuclear export, is active in bone and soft tissue sarcoma
    Meeting Abstract

    Nair, J. S.; Tap, W.; Vasudeva, S. D.; Sicklick, J. K.; Kauffman, M.; Shacham, S.; Schwartz, G. K.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial
    Journal Article

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S. M.; Reed, D. R.; Okuno, S. H.; more...
    Lancet Oncology (2013)

    Fulltext@MSK | Save